Affiliation:
1. National Medical Research Center of Phthisiopulmonology and Infectious Diseases, Russian Ministry of Health; Pirogov Russian National Research Medical University, Russian Ministry of Health
2. National Medical Research Center of Phthisiopulmonology and Infectious Diseases, Russian Ministry of Health
Abstract
The objective: to evaluate the efficacy of chemotherapy regimens for isoniazid resistant pulmonary tuberculosis (Hr-TB): short-course regimen consisting of 4 components (non-injection) and the regimen consisting of 5 components (standard regimen).Subjects and Methods. Medical records of 292 pulmonary tuberculosis patients with resistance to isoniazid were retrospectively studied. In 89 patients (Group A), the regimen containing rifampicin, pyrazinamide, ethambutol, and levofloxacin was used – a 4-component non-injection regimen (180±20 doses). In 203 patients (Group B), the regimen containing rifampicin, pyrazinamide, ethambutol, levofloxacin, and amikacin/kanamycin was used - a 5-component standard regimen (270 doses).Results. The efficacy of treatment of isoniazid resistant pulmonary tuberculosis was similar, while a short-term 4-component (non-injection) regimen is 4.5 times less expensive versus the standard 5-component regimen. Treatment success made 88.8% and 88.2% respectively, p>0.05.
Publisher
LLC "Medical Knowledge and Technologies"
Reference8 articles.
1. Burmistrova I.A., Vaniev E.V., Samoylova A.G., Lovacheva O.V., Vasilyeva I.A. Amplification of drug resistance against the background of inadequate chemotherapy for pulmonary tuberculosis. Tuberculosis and Lung Diseases, 2019, vol. 97, no. 8, pp. 46-51. (In Russ.) https://doi.org/10.21292/2075-1230-2019-97-8-46-51.
2. Vasilyeva I.A., Belilovskiy E.M., Borisov S.E., Sterlikov S.A. Multiple drug resistant tuberculosis in the world and Russian Federation. Tuberculosis and Lung Diseases, 2017, vol. 95, no. 11, pp. 5-17. (In Russ.) https://doi.org/10.21292/2075-1230-2017-95-11-5-17
3. Ivanova D.A.Nezhelatelnye reaktsii pri lechenii vpervye vyyavlennykh bolnykh tuberkulezom organov dykhaniya: profilaktika, rannyaya diagnostika i kupirovanie. Avtoref. diss. dokt. med. nauk. [Adverse reactions to treatment of new respiratory tuberculosis cases: prevention, early diagnostics and management. Synopsis of Doct. Diss.]. 14.01.16, Moscow, 2018, 41 p. Available: https://search.rsl.ru/ru/record/01008708323 Accessed October 10, 2023
4. Edict Russia no. 951 by RF MoH as of December 29, 2014 On Approval of Guidelines for Improvement of Respiratory Tuberculosis Diagnostics Treatment. (In Russ.) Available: https://minobr.permkrai.ru/dokumenty/40838/ Accessed September 30, 2023
5. Gegia M., Winters N., Benedetti A. et al. Treatment of isoniazid-resistant tuberculosis with first-line drugs: a systematic review and meta-analysis. Lancet Infect. Dis., 2017, vol. 17, no. 2, pp. 223-234.